Eteplirsen
4658-204
Phase 3 small_molecule active
Quick answer
Eteplirsen for Muscular Dystrophy, Duchenne is a Phase 3 program (small_molecule) at Sarepta Therapeutics with 2 ClinicalTrials.gov record(s).
Program details
- Company
- Sarepta Therapeutics
- Indication
- Muscular Dystrophy, Duchenne
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active